Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.56 |
| ▸ | TSHR | P16473 | 5/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.56 |
| ▸ | MAPT | P10636 | 4/20 | 0.56 |
| ▸ | MEN1 | O00255 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.56 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.46 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30393904 | 1.00 | CYP3A4 (0.56) | CYP3A4TSHRALDH1A1TDP1MAPT | |
| SCHEMBL3243151 | 0.92 | MAPT (0.60) | CYP3A4TSHRALDH1A1TDP1MAPT | |
| SCHEMBL9378154 | 0.89 | MAPT (0.58) | CYP3A4TSHRALDH1A1TDP1MAPT | |
| SCHEMBL19511923 | 0.88 | MAPT (0.62) | CYP3A4TSHRALDH1A1TDP1MAPT | |
| SCHEMBL28270438 | 0.87 | CYP3A4 (0.50) | CYP3A4TSHRALDH1A1TDP1MAPT | |
| SCHEMBL24570650 | 0.83 | ALDH1A1 (0.47) | CYP3A4TSHRALDH1A1TDP1MAPT | |
| SCHEMBL8002989 | 0.83 | ALDH1A1 (0.53) | CYP3A4TSHRALDH1A1TDP1MAPT | |
| SCHEMBL11207797 | 0.83 | TSHR (0.59) | CYP3A4TSHRALDH1A1TDP1MAPT | |
| SCHEMBL10942341 | 0.83 | ALDH1A1 (0.71) | CYP3A4TSHRALDH1A1TDP1MAPT | |
| SCHEMBL1192850 | 0.83 | ALDH1A1 (0.71) | CYP3A4TSHRALDH1A1TDP1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111471019-B | 5, 6-dinitrobenzimidazole compound and synthesis method and application thereof | 浙江工业大学 | 2021-10-01 | — | — | CN | claimed |
| CN-112409364-A | Hexaazanaphthalene derivative and preparation method and application thereof | 常州大学 | 2021-02-26 | — | — | CN | claimed |
| CN-111471019-A | 5, 6-dinitrobenzimidazole compound and synthesis method and application thereof | 浙江工业大学 | 2020-07-31 | — | — | CN | claimed |
| CN-108658993-B | Pyreneimide derivative and synthesis method and application thereof | 兰州大学 | 2020-07-10 | — | — | CN | claimed |
| CN-101270089-B | Benzimidazole-containing chromophore and synthetic method thereof | UNIV ZHEJIANG | 2012-05-02 | — | — | CN | claimed |
| CN-101270089-A | Chromogen containing benzimidazole and synthesizing process | UNIV ZHEJIANG (CN) | 2008-09-24 | — | — | CN | claimed |
| CN-1098842-C | Organic second nonlinear optic response chromophore compound | CHINESE ACAD INST CHEMISTRY (CN) | 2003-01-15 | — | — | CN | claimed |
| CN-1218804-A | Organic second nonlinear optic response chromophore compound | CHINESE ACAD INST CHEMISTRY (CN) | 1999-06-09 | — | — | CN | claimed |
| US-11667845-B2 | Liquid crystalline medium | MERCK PATENT GMBH (DE) | 2023-06-06 | — | — | US | disclosed |
| CN-116143790-A | Functionalized hexaazabenzophenanthryl lithium ion battery positive electrode material, and preparation method and application thereof | 北京化工大学 | 2023-05-23 | — | — | CN | disclosed |
| CN-112409364-B | Hexaazanaphthalene derivative and preparation method and application thereof | 常州大学 | 2022-02-11 | — | — | CN | disclosed |
| CN-111471019-B | 5, 6-dinitrobenzimidazole compound and synthesis method and application thereof | 浙江工业大学 | 2021-10-01 | — | — | CN | disclosed |
| CN-111620894-B | Photosensitizer based on thiadiazole [3,4-g ] quinoxaline structure and preparation method and application thereof | 中国科学院理化技术研究所 | 2021-09-07 | — | — | CN | disclosed |
| US-20210238481-A1 | LIQUID CRYSTALLINE MEDIUM | MERCK PATENT GMBH (JP) | 2021-08-05 | — | — | US | disclosed |
| EP-0119271-A1 | LIQUID CRYSTALLINE POLYMER COMPOSITIONS, PROCESS, AND PRODUCTS. | STANFORD RES INST INT (US) | 1984-09-26 | — | — | EP | disclosed |
| WO-1984001161-A1 | LIQUID CRYSTALLINE POLY(2,6-BENZOTHIAZOLE) COMPOSITIONS, PROCESS AND PRODUCTS | STANFORD RES INST INT (US) | 1984-03-29 | — | — | WO | disclosed |
| WO-1984001160-A1 | LIQUID CRYSTALLINE POLYMER COMPOSITIONS, PROCESS, AND PRODUCTS | STANFORD RES INST INT (US) | 1984-03-29 | — | — | WO | disclosed |
| WO-1984001162-A1 | LIQUID CRYSTALLINE POLYMER COMPOSITIONS, PROCESS, AND PRODUCTS | STANFORD RES INST INT (US) | 1984-03-29 | — | — | WO | disclosed |
| US-4020068-A | Chromogenic furoquinoxalines | NCR CORPORATION (US) | 1977-04-26 | — | — | US | disclosed |
| US-4001268-A | SUBSTITUTED PHENYL-BENZIMIDAZO COMPOUNDS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE AIR FORCE (US) | 1977-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210238481-A1 | LIQUID CRYSTALLINE MEDIUM | NEFM, CCNI, MYT1 | CYP3A4 328/4885TSHR 3699/4885ALDH1A1 1933/4885 |
| US-11667845-B2 | Liquid crystalline medium | NEFM, CCNI, MYT1 | CYP3A4 328/4885TSHR 3699/4885ALDH1A1 1933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.